SNOA icon

Sonoma Pharmaceuticals
SNOA

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $144K invested in Sonoma Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

10% less capital invested

Capital invested by funds: $159K → $144K (-$15.8K)

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$16K
2
+$13K
3
+$6.81K
4
ASN
Advisory Services Network
Georgia
+$2.4K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$1K

Top Sellers

1
-$31.8K
2
-$3.28K
3
-$527
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$41K
2
$35.4K
3
$23K
4
$16K
5
$13K
6
$8K
7
$2.81K
8
$2.4K
9
$1K
10
$488
11
$210
12
$84
13
$64
14
$43
15
$30
16
$21
17
$10
18
–